Sarepta Therapeutics Inc. (SRPT)
undefined
undefined%
At close: undefined
122.00
-1.27%
After-hours Dec 13, 2024, 06:16 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99 FY98 FY97 FY96 FY95
Revenue 1.24B 933.01M 701.89M 540.10M 380.83M 301.03M 154.58M 5.42M 1.25M 9.76M 14.22M 37.33M 46.99M 29.42M 17.59M 21.26M 10.99M 115.29K 4.78M 430.46K 969.87K 836.78K 706.10K 1.30M 100.00K 200.00K 100.00K 100.00K 100.00K
Cost of Revenue 150.34M 139.99M 97.05M 63.38M 56.59M 34.19M 7.35M 130.00K 146.19M 94.10M 90.28M 51.93M 35.93M 27.46M - - - - - - - - - -416.50K - -200.00K -500.00K -500.00K -
Gross Profit 1.09B 793.02M 604.84M 476.72M 324.25M 266.84M 147.23M 5.29M -144.94M -84.35M -76.06M -14.60M 11.06M 1.96M 17.59M 21.26M 10.99M 115.29K 4.78M 430.46K 969.87K 836.78K 706.10K 1.71M 100.00K 400.00K 600.00K 600.00K 100.00K
Operating Income -267.82M -536.20M -449.71M -564.16M -522.32M -343.63M -171.64M -266.73M -220.18M -133.79M -90.28M -29.70M -35.93M -20.93M -15.51M -27.46M -33.11M -32.98M -17.52M -25.04M -18.87M -25.34M -15.40M -10.24M -8.30M -7.70M -3.90M -2.20M -2.60M
Interest Income 85.97M 16.49M 354.00K 2.97M 7.24M 6.81M 1.81M 507.00K - - - - 677.00K - - - - 1.91M 840.50K - 491.10K - - 1.00M - - - - -
Pretax Income -520.10M -689.96M -418.95M -553.07M -713.88M -362.61M -48.63M -267.26M -220.03M -135.79M -111.98M -121.29M -2.32M -23.95M -24.70M -23.95M -28.15M -31.07M -16.68M -24.78M -14.62M -29.36M -8.28M -9.24M -8.40M -26.70M -3.50M -2.00M -2.60M
Net Income -535.98M -703.49M -418.78M -554.13M -715.08M -361.92M -50.69M -267.26M -220.03M -135.79M -111.98M -121.29M -2.32M -32.18M -25.16M -23.95M -27.17M -31.07M -16.68M -24.78M -14.62M -29.36M -26.93M -9.24M -8.30M -26.70M -3.60M -2.10M -2.60M
Selling & General & Admin 481.87M 451.42M 282.66M 317.88M 284.81M 207.76M 122.68M 83.75M 75.04M 49.31M 31.59M 14.63M 16.05M 14.38M 8.70M 9.80M 9.33M 7.75M 5.18M 4.74M 4.56M 3.76M 3.36M 2.27M 1.70M 1.60M 1.30M 600.00K 600.00K
Research & Development 877.39M 877.09M 771.18M 722.34M 560.91M 401.84M 166.71M 188.27M 146.39M 94.23M 72.91M 52.40M 66.86M 35.97M 24.40M 29.00M 34.76M 25.35M 17.12M 20.74M 15.28M 22.41M 12.75M 9.27M 6.70M 6.30M 2.70M 1.70M 2.10M
Other Expenses 1.56M 714.00K 706.00K 662.00K 849.00K -656.00K 1.98M - - - - - - - - - - - - - - - - 416.50K - 200.00K 500.00K 500.00K -
Operating Expenses 1.36B 1.33B 1.05B 1.04B 846.57M 610.47M 290.44M 272.02M 221.44M 143.55M 104.50M 67.03M 82.92M 50.35M 33.09M 38.80M 44.09M 33.10M 22.30M 25.47M 19.84M 26.18M 16.11M 11.96M 8.40M 8.10M 4.50M 2.80M 2.70M
Interest Expense 22.01M 53.25M 63.52M 59.95M 30.67M 33.71M 5.78M 1.89M - - 326.00K - 90.00K 344.00K 454.00K 344.00K - - - - - - - - - - - - -
Selling & Marketing Expenses 28.60M 14.60M 7.70M - - -2.22M 2.83M 2.55M - - - - - - - - - - - - - - - - - - - - -
Cost & Expenses 1.51B 1.47B 1.15B 1.10B 903.16M 644.66M 297.80M 272.15M 221.44M 143.55M 104.50M 67.03M 82.92M 50.35M 33.09M 38.80M 44.09M 33.10M 22.30M 25.47M 19.84M 26.18M 16.11M 11.54M 8.40M 7.90M 4.00M 2.30M 2.70M
Income Tax 15.88M 13.53M -168.00K 1.06M 1.20M -692.00K 2.06M -7.62M -5.25M -1.69M 20.42M 91.58M -34.91M 11.24M 9.65M 6.41M -5.94M - - - -4.26M 4.02M 11.52M - - 19.00M -300.00K -100.00K -
Shares Outstanding (Basic) 92.40M 87.56M 81.26M 77.96M 73.61M 66.25M 58.82M 48.68M 42.29M 40.03M 33.83M 23.60M 21.60M 18.54M 15.52M 11.58M 8.99M 8.78M 7.44M 6.00M 4.97M 4.28M 3.73M 3.12M 2.24M 1.97M 1.68M 1.40M 1.20M
Shares Outstanding (Diluted) 92.40M 87.56M 81.26M 77.96M 73.61M 66.25M 58.82M 48.70M 42.29M 40.03M 33.85M 23.60M 21.60M 18.54M 15.52M 11.58M 8.99M 8.78M 7.44M 6.00M 4.97M 4.28M 3.73M 3.12M 2.24M 1.97M 1.68M 1.40M 1.20M
EPS (Basic) -5.8 -8.03 -5.15 -7.11 -9.71 -5.46 -0.86 -5.49 -5.2 -3.39 -3.31 -5.14 -0.11 -1.74 -1.62 -2.07 -3.02 -3.54 -2.24 -4.13 -2.94 -6.86 -7.21 -2.96 -3.71 -13.57 -2.14 -1.5 -2.17
EPS (Diluted) -5.8 -8.03 -5.15 -7.11 -9.71 -5.46 -0.86 -5.49 -5.2 -3.39 -3.31 -5.14 -0.11 -1.74 -1.62 -2.07 -3.02 -3.54 -2.24 -4.13 -2.94 -6.86 -7.21 -2.96 -3.71 -13.57 -2.14 -1.5 -2.17
EBITDA -439.20M -582.12M -306.08M -453.38M -652.66M -316.66M -34.75M -261.12M -214.78M -129.97M -88.42M -27.59M -34.63M -19.47M -14.13M -22.48M -25.15M -28.98M -14.68M -22.89M -17.39M -24.01M -14.85M -9.82M -8.00M -7.60M -3.40M -1.70M -2.10M
Depreciation & Amortization 58.89M 54.60M 49.34M 39.74M 30.55M 12.24M 8.09M 5.61M 5.25M 3.69M 1.28M 1.52M 1.30M 1.46M 1.38M 1.47M 2.01M 2.09M 2.00M 1.89M 1.48M 1.33M 556.47K 416.50K 300.00K 200.00K 500.00K 500.00K 500.00K